Atossa Therapeutics
ATOS
#9542
Rank
HK$0.57 B
Marketcap
HK$4.41
Share price
-5.83%
Change (1 day)
-32.59%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -HK$1.95

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$1.95. In 2024 the company made an earnings per share (EPS) of -HK$1.56 an increase over its 2023 EPS that were of -HK$1.88.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$1.9524.77%
2024-HK$1.56-16.67%
2023-HK$1.8814.29%
2022-HK$1.6416.67%
2021-HK$1.41-90.86%
2020-HK$15.39-2.96%
2019-HK$15.86-63.09%
2018-HK$42.97-49.63%
2017-HK$85.32-57.87%
2016-HK$202.51-74.01%
2015-HK$779.09-9.18%
2014-HK$857.83-12.86%
2013-HK$984.4070.73%
2012-HK$576.5834.08%
2011-HK$430.03263.47%
2010-HK$118.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.56-4,275.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$67.50-3,556.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$80.08-4,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-HK$6.88 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-HK$1.64-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA